Correction to: Clinical disease progression and biomarkers in Niemann-Pick disease type C: a prospective cohort study

Affiliations

• ¹ SphinCS GmbH, Institute of Clinical Science for LSD, Hochheim, Germany. eugen.mengel@sphincs.de.
• ² Regional Coordinator Centre for Rare Diseases, Academic Hospital Santa Maria Della Misericordia, Udine, Italy.
• ³ Vall D'Hebron University Hospital, Barcelona, Spain.
• ⁴ Ospedale Pediatrico Bambino Gesù, IRCCS, 00146, Rome, Italy.
• ⁵ Inselspital, University Hospital of Bern, Bern, Switzerland.
• ⁶ Metabolic Department, Great Ormond Street Hospital NHS Foundation Trust, Institute for Child Health, NIHR Biomedical Research Centre UCL, London, UK.
• ⁷ Centre for Inherited Metabolic Diseases, Copenhagen University Hospital (Rigshospitalet), Copenhagen, Denmark.
• ⁸ Reference Centre for Lysosomal Disease, Trousseau University Hospital, Paris, France.
• ⁹ Dr. Von Hauner Children's Hospital, University of Munich, Munich, Germany.
• ¹⁰ Institute of Neurosciences, University Hospital of Montpellier, Montpellier, France.
• ¹¹ Birmingham Children's Hospital, Birmingham, UK.
• ¹² Children's Memorial Health Institute, Warsaw, Poland.
• ¹³ Clinical Trials Consulting and Training Limited, Buckingham, UK.
• ¹⁴ Clinical Outcomes Solutions Limited, Folkestone, UK.
• ¹⁵ Clinical Outcomes Solutions Inc, Tucson, AZ, USA.
• ¹⁶ Mayo Clinic Children's Center, Rochester, MN, USA.
• ¹⁷ Orphazyme A/S, Copenhagen, Denmark.